Sanofi Q4 Adj. EPADS $0.89 Misses $1.50 Estimate, Sales $11.75B Miss $12.26B Estimate
Portfolio Pulse from Benzinga Newsdesk
Sanofi (NASDAQ:SNY) reported Q4 adjusted earnings per share (EPS) of $0.89, missing the consensus estimate of $1.50 by 40.67%. Quarterly sales were $11.75B, also below the expected $12.26B. Despite these misses, both earnings and sales showed an increase from the same period last year, with earnings up 2.3% and sales up 9.59%.
February 01, 2024 | 6:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sanofi's Q4 earnings and sales missed analyst estimates, with EPS at $0.89 against an expected $1.50 and sales at $11.75B versus $12.26B forecasted. However, there was a year-over-year growth in both metrics.
Missing both EPS and sales estimates significantly is likely to have a negative impact on investor sentiment and could lead to a short-term decline in Sanofi's stock price. However, the year-over-year growth may provide some cushion to the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100